[Bronchodilators in babies with wheezy bronchitis (author's transl)].
In 16 babies aged one month to 11 months, lung mechanics were studied before and after subcutaneous injection of a bronchodilator; in addition, total serum IgE and various Virus-Complement-Binding Reactions (CBR) were determined. All the babies showed the clinical signs of bronchial obstruction, but the total lung resistance and the dynamic lung compliance were not significantly altered after the injection. No relationship existed between the height of the serum IgE-value and the results of the Virus-CBR. It could not be confirmed that babies with wheezy bronchitis and a raised IgE-value reacted any better to the bronchodilator than babies with bronchial obstruction and a normal IgE-value.
D001249:Asthma / Q000188:drug therapy; D001990:Bronchiolitis, Viral / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy*; D003168:Complement Fixation Tests; D005260:Female; D006801:Humans; D007073:Immunoglobulin E / Q000032:analysis; D007223:Infant; D007279:Injections, Subcutaneous; D008170:Lung Compliance; D008297:Male; D012129:Respiratory Function Tests; D013726:Terbutaline / Q000008:administration & dosage / Q000627:therapeutic use*
D007073:Immunoglobulin E; D013726:Terbutaline
Bronchospasmolytische Therapie bei Säuglingen mit obstruktiver Bronchitis.